Fondazione Pascale, IRCCS, Istituto Nazionale dei Tumori

Naples 80131

0 studies enrolling now · 3 studies all time

What they study most

Adult T Cell Leukemia/Lymphoma, Genes, BRCA 1, HER-2 Positive Breast Cancer, Locally Advanced or Metastatic Solid Tumors, Metastatic Neoplasm, Relapsed/Refractory Peripheral T-Cell Lymphoma

Studies at this site

• Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) — Running, not enrolling
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors — Stopped early